BridgeBio Oncology Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
BridgeBio Oncology Therapeutics, Inc. (BBOT) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 12.88 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-11
- BridgeBio Oncology Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 12.43M shares, a 97.40% decline year-over-year.
- BridgeBio Oncology Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 477.39M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 12.88M shares 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | 12.43M shares 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | 9.04M shares POS AM · filed 2026-04-30 | |||
| 2025-09-30 | 8.23M shares 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | 42.97M shares 10-Q · filed 2026-08-11 | |||
| 2025-03-31 | 477.39M shares 10-Q · filed 2026-05-12 | |||
| 2024-12-31 | 42.54M shares POS AM · filed 2026-04-30 | |||
| 2024-09-30 | 42.28M shares 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |